Xu Steven Xu

21PUBLICATIONS
31CO-AUTHORS
Molecular targetsGene and molecular therapyHaematological tumoursAutoimmunityPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 17, 2026
Molecular Profiling of Tisotumab Vedotin-Treated Patients Identifies Immune Pathways Associated With Clinical Activity.

|Jul 16, 2026
Transitioning Therapeutic Antibodies in Oncology from Intravenous to Hyaluronidase-Facilitated Subcutaneous Administration.

|Jul 07, 2026
Epcoritamab Step-Up Dosing Regimen Selection and Optimization Using Repeated Time-to-Event Modeling for Cytokine Release Syndrome Risk Mitigation.

|Jun 05, 2026
Translating B-Cell and Plasma-Cell Targeting from Oncology to Autoimmunity: Modalities, Quantitative Bridging, and a Development Roadmap.

|May 15, 2026
Model-Informed Dosing Strategies for Epcoritamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma.

|Mar 02, 2026
QT Prolongation Risk of Antibody-Drug Conjugates.

Xu Steven Xu, Kinjal Sanghavi, Summer Feng

Pageof 4

Frequent Collaborators

4 joint publications

Min Yuan

3 joint publications

Tommy Li

2 joint publications

Jitendra Jonnagaddala

2 joint publications

Hong Zhang